Home / Licensed and specials products / Central Nervous System / Rivastigmine Rosemont Oral Solution

Rivastigmine Rosemont Oral Solution

= Standard font size
= Large font size
= Audio version
= Strength
= Summary of Product Characteristics
= Watery Liquid
= Slightly thicker than water
= Thick liquid
1 = Licensed tested open bottle shelf life
2 = "Special" tested open bottle shelf life
3 = Recommended open bottle shelf life
2mg/ml
Pack Size 120ml
Colour Clear yellow
Flavour None
Sucrose Free yes
Lactose Free yes
Diabetic Safe yes
Gluten Free yes
Storage Conditions Do not store above 30°C. Do not refrigerate or freeze
Excipients
See List
Sodium Levels Essentially sodium-free
Ethanol Concentration None
Glucose Free yes
Sorbitol Free yes
Fructose Free yes
Aspartame Free yes
Tartrazine Free yes
Arachis Oil Free yes
Sesame Oil Free yes
Suitable for Kosher yes
Suitable for Halal yes
Suitable for vegan yes
PIP Code 120-2126
EAN Code 50-16119-31679-1
Shelf Life (Closed Bottle/Open Bottle) 48 months / 1 month 1
Patient Information - Audio
Patient Information
SPC
Halal Certification
2mg/ml
Pack Size 120ml
Colour Clear yellow
Flavour None
Sucrose Free yes
Lactose Free yes
Diabetic Safe yes
Gluten Free yes
Storage Conditions Do not store above 30°C. Do not refrigerate or freeze
Excipients
See List
Sodium Levels Essentially sodium-free
Ethanol Concentration None
Glucose Free yes
Sorbitol Free yes
Fructose Free yes
Aspartame Free yes
Tartrazine Free yes
Arachis Oil Free yes
Sesame Oil Free yes
Suitable for Kosher yes
Suitable for Halal yes
Suitable for vegan yes
PIP Code 120-2126
EAN Code 50-16119-31679-1
Shelf Life (Closed Bottle/Open Bottle) 48 months / 1 month 1
Patient Information - Audio
Patient Information
SPC
Halal Certification

Copyright © 2023 Rosemont Pharmaceuticals Limited. All rights reserved. Rosemont Pharmaceuticals Limited is a registered company in England & Wales.
Terms & Conditions - Modern Slavery Statement - Anti-Corruption & Anti-Bribery Policy - Corporate Criminal Offence Policy - Whistleblowing Policy - Disclosure of Payments & Transfers - COVID-19 Risk Assessment

Terms of Use | Privacy Policy |Cookie Preferences